Facilitated percutaneous coronary intervention: Current concepts, promises, and pitfalls

Thomas J. Kiernan, Henry H. Ting, Bernard J. Gersh

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The reperfusion era has dramatically and irrevocably transformed the management of ST-segment elevation myocardial infarction (STEMI). For the patient treated with fibrinolysis as the initial reperfusion strategy, subsequent options which are the subject of some controversy and the focus of this review are (i) facilitated percutaneous coronary intervention (PCI); (ii) pharmacoinvasive approach; (iii) 'Watchful waiting'. We performed a literature search of all available articles on facilitated PCI published in English language on Medline, including randomized controlled trials, meta-analyses, and review articles. This information provided the core for a critical appraisal of the current literature on this controversial topic. On the basis of current available data, facilitated PCI with a thrombolytic agent has no role in everyday clinical practice and facilitated PCI utilizing a glycoprotein IIbIIIa inhibitor agent has no considerable benefit on mortality in STEMI in contemporary practice. The evidence to date suggests that fibrinolytic- facilitated PCI is associated with higher mortality rates and adverse events compared with primary PCI.

Original languageEnglish (US)
Pages (from-to)1545-1553
Number of pages9
JournalEuropean Heart Journal
Volume28
Issue number13
DOIs
StatePublished - Aug 2007

Fingerprint

Percutaneous Coronary Intervention
Reperfusion
Watchful Waiting
Fibrinolytic Agents
Mortality
Fibrinolysis
Meta-Analysis
Glycoproteins
Language
Randomized Controlled Trials

Keywords

  • Facilitated percutaneous coronary intervention
  • ST-elevation myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Facilitated percutaneous coronary intervention : Current concepts, promises, and pitfalls. / Kiernan, Thomas J.; Ting, Henry H.; Gersh, Bernard J.

In: European Heart Journal, Vol. 28, No. 13, 08.2007, p. 1545-1553.

Research output: Contribution to journalArticle

Kiernan, Thomas J. ; Ting, Henry H. ; Gersh, Bernard J. / Facilitated percutaneous coronary intervention : Current concepts, promises, and pitfalls. In: European Heart Journal. 2007 ; Vol. 28, No. 13. pp. 1545-1553.
@article{80997773081c4a2fbc72c00e14dc67a8,
title = "Facilitated percutaneous coronary intervention: Current concepts, promises, and pitfalls",
abstract = "The reperfusion era has dramatically and irrevocably transformed the management of ST-segment elevation myocardial infarction (STEMI). For the patient treated with fibrinolysis as the initial reperfusion strategy, subsequent options which are the subject of some controversy and the focus of this review are (i) facilitated percutaneous coronary intervention (PCI); (ii) pharmacoinvasive approach; (iii) 'Watchful waiting'. We performed a literature search of all available articles on facilitated PCI published in English language on Medline, including randomized controlled trials, meta-analyses, and review articles. This information provided the core for a critical appraisal of the current literature on this controversial topic. On the basis of current available data, facilitated PCI with a thrombolytic agent has no role in everyday clinical practice and facilitated PCI utilizing a glycoprotein IIbIIIa inhibitor agent has no considerable benefit on mortality in STEMI in contemporary practice. The evidence to date suggests that fibrinolytic- facilitated PCI is associated with higher mortality rates and adverse events compared with primary PCI.",
keywords = "Facilitated percutaneous coronary intervention, ST-elevation myocardial infarction",
author = "Kiernan, {Thomas J.} and Ting, {Henry H.} and Gersh, {Bernard J.}",
year = "2007",
month = "8",
doi = "10.1093/eurheartj/ehm222",
language = "English (US)",
volume = "28",
pages = "1545--1553",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Facilitated percutaneous coronary intervention

T2 - Current concepts, promises, and pitfalls

AU - Kiernan, Thomas J.

AU - Ting, Henry H.

AU - Gersh, Bernard J.

PY - 2007/8

Y1 - 2007/8

N2 - The reperfusion era has dramatically and irrevocably transformed the management of ST-segment elevation myocardial infarction (STEMI). For the patient treated with fibrinolysis as the initial reperfusion strategy, subsequent options which are the subject of some controversy and the focus of this review are (i) facilitated percutaneous coronary intervention (PCI); (ii) pharmacoinvasive approach; (iii) 'Watchful waiting'. We performed a literature search of all available articles on facilitated PCI published in English language on Medline, including randomized controlled trials, meta-analyses, and review articles. This information provided the core for a critical appraisal of the current literature on this controversial topic. On the basis of current available data, facilitated PCI with a thrombolytic agent has no role in everyday clinical practice and facilitated PCI utilizing a glycoprotein IIbIIIa inhibitor agent has no considerable benefit on mortality in STEMI in contemporary practice. The evidence to date suggests that fibrinolytic- facilitated PCI is associated with higher mortality rates and adverse events compared with primary PCI.

AB - The reperfusion era has dramatically and irrevocably transformed the management of ST-segment elevation myocardial infarction (STEMI). For the patient treated with fibrinolysis as the initial reperfusion strategy, subsequent options which are the subject of some controversy and the focus of this review are (i) facilitated percutaneous coronary intervention (PCI); (ii) pharmacoinvasive approach; (iii) 'Watchful waiting'. We performed a literature search of all available articles on facilitated PCI published in English language on Medline, including randomized controlled trials, meta-analyses, and review articles. This information provided the core for a critical appraisal of the current literature on this controversial topic. On the basis of current available data, facilitated PCI with a thrombolytic agent has no role in everyday clinical practice and facilitated PCI utilizing a glycoprotein IIbIIIa inhibitor agent has no considerable benefit on mortality in STEMI in contemporary practice. The evidence to date suggests that fibrinolytic- facilitated PCI is associated with higher mortality rates and adverse events compared with primary PCI.

KW - Facilitated percutaneous coronary intervention

KW - ST-elevation myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=34547780077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547780077&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehm222

DO - 10.1093/eurheartj/ehm222

M3 - Article

C2 - 17573380

AN - SCOPUS:34547780077

VL - 28

SP - 1545

EP - 1553

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 13

ER -